Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
LETTER
Albert E Zhou, Jane M Grant-Kels
No abstract text is available yet for this article.
September 24, 2023: Journal of the American Academy of Dermatology
#2
JOURNAL ARTICLE
Yun-Wen Chen, Hsin-Hua Chen, Wen-Nan Huang, Chiann-Yi Hsu, Yi-Hsing Chen, Wei-Ting Hung, Kuo-Tung Tang
No abstract text is available yet for this article.
September 24, 2023: Journal of the American Academy of Dermatology
#3
LETTER
Haarika A Reddy, Alexander Maytin, Dustin DeMeo, Caroline Wilkowski, Bryan T Carroll
No abstract text is available yet for this article.
September 24, 2023: Journal of the American Academy of Dermatology
#4
LETTER
Alana L Ferreira, Benjamin Stoff, Jane M Grant-Kels
No abstract text is available yet for this article.
September 24, 2023: Journal of the American Academy of Dermatology
#5
JOURNAL ARTICLE
R C Velasco, C Shao, T M Greiling
No abstract text is available yet for this article.
September 23, 2023: Journal of the American Academy of Dermatology
#6
JOURNAL ARTICLE
Seemal R Desai, Andrew F Alexis, Nada Elbuluk, Pearl E Grimes, Jonathan Weiss, Iltefat H Hamzavi, Susan C Taylor
BACKGROUND: Melasma is a chronic hypermelanosis of the skin that affects roughly one percent of the global population, predominantly affects women, and is more prevalent in skin of color.1,2 Melasma is a common driver for patients with skin of color to seek out a dermatologist for treatment, and ensuring the right approach for these patients is important as some treatments may be associated with adverse side effects.3 Due to the chronicity of the disease and established psychosocial and emotional impacts, there is a large need to ensure care follows the best available evidence on the treatment of patients with melasma...
September 23, 2023: Journal of the American Academy of Dermatology
#7
JOURNAL ARTICLE
Robert T Brodell
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#8
JOURNAL ARTICLE
Robert T Brodell
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#9
JOURNAL ARTICLE
M Lery, A Perrot, A Ortiz-Brugués, E Vigarios, D Anghel, P Bories, V Sibaud
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#10
JOURNAL ARTICLE
Robert T Brodell
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#11
JOURNAL ARTICLE
Faramarz Samie
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#12
EDITORIAL
Dirk M Elston
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#13
JOURNAL ARTICLE
Robert T Brodell
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#14
JOURNAL ARTICLE
Matthew P Dizon, Eleni Linos, Susan M Swetter
BACKGROUND: Active surveillance may be considered for low-risk basal cell carcinomas (BCC) in patients with limited life expectancy; however, estimates of life expectancy are not readily available. Veterans Health Administration's (VHA) Care Assessment Need (CAN) score may address this problem. OBJECTIVE: We examined the CAN score's performance in predicting 1-, 3-, and 5-year mortality in United States (US) veterans with BCC. METHODS: This retrospective cohort study used national VHA electronic medical record data...
September 22, 2023: Journal of the American Academy of Dermatology
#15
JOURNAL ARTICLE
Andrew Patterson
No abstract text is available yet for this article.
September 22, 2023: Journal of the American Academy of Dermatology
#16
JOURNAL ARTICLE
Bruce Strober, Laura Ferris, Kristina Callis Duffin, Jud C Janak, Adam P Sima, Thomas Eckmann, Manish Patel, Huzefa Photowala, Vishvas Garg, April Armstrong
BACKGROUND: Psoriasis, an inflammatory skin disease, is often treated with biologic therapeutics. OBJECTIVE: To determine the real-world treatment effectiveness of risankizumab, an IL-23 inhibitor, in the treatment of moderate-to-severe plaque psoriasis. METHODS: A retrospective, observational study was conducted using the CorEvitas Psoriasis Registry for eligible adults with a diagnosis of moderate-to-severe psoriasis and persistent use of risankizumab at 12 (±3) months after initiation...
September 20, 2023: Journal of the American Academy of Dermatology
#17
JOURNAL ARTICLE
Amit Garg, Megan H Noe, Milan J Anadkat, April Armstrong, Tina Bhutani, Aaron Farberg, George Han, Jason E Hawkes, Mark Lebwohl, Sergey Rekhtman, Eingun James Song, Andrew Strunk, Kristina Callis Duffin
No abstract text is available yet for this article.
September 20, 2023: Journal of the American Academy of Dermatology
#18
JOURNAL ARTICLE
Sarah Gonzalez, Nicole Syder, Shanice A McKenzie, Kyla N Price, Binh Ngo, Arielle Carolina Mora Hurtado, Jack Rodman, Nada Elbuluk
No abstract text is available yet for this article.
September 19, 2023: Journal of the American Academy of Dermatology
#19
JOURNAL ARTICLE
Emily E Granger, Emily Y Kim, Emily Karn, Morgan K Groover, Ann W Silk, Danielle N Margalit, Roy B Tishler, Jonathan D Schoenfeld, Emily S Ruiz
No abstract text is available yet for this article.
September 19, 2023: Journal of the American Academy of Dermatology
#20
JOURNAL ARTICLE
Gloria F Chen, Suyeon Hong, Sarika M Ramachandran, Jeff R Gehlhausen, Jeffrey M Cohen
No abstract text is available yet for this article.
September 19, 2023: Journal of the American Academy of Dermatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
